Onset and duration of action of lokivetmab in a canine model of IL-31 induced pruritus.

These data indicate that a single subcutaneous injection of 2 mg/kg lokivetmab produces a significant suppression of pruritus starting 3 h post-treatment that can be sustained for 42 days.